secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001104659-25-072731
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q2 revenue +4.5% to $1.34B, EPS $0.32, reaffirms FY2025 outlook
------------------------------------------------------------------------------

- Revenue $1,339.6M (+4.5% YoY); net income from continuing ops $57.9M (+53.8%).
- Adjusted EBITDA $125.4M (+0.5% YoY); diluted EPS $0.32 vs $0.17 (+88.2%).
- Rehab hospital revenue +17.2% to $313.8M; critical illness revenue -0.6% to $601.1M.
- Reaffirms FY2025 revenue $5.3B-$5.5B, Adj EBITDA $510M-$530M, EPS $1.09-$1.19.
- Declares $0.0625/share cash dividend (payable Aug 28); $1B buyback program ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465925072731/0001104659-25-072731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465925072731/tm2522098d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-072731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer